https://www.selleckchem.com/pr....oducts/cytidine-5-tr
DRB1*11260 differs from DRB1*110301 by one nucleotide substitution at position 484 in exon 3.In the present study, we have investigated potential cardioprotective properties of Isosteviol analogue we recently synthesized and named JC105. Treatment of heart embryonic H9c2 cells with JC105 (10 μM) significantly increased survival of cells exposed to hypoxia-reoxygenation. JC105 (10 μM) activated ERK1/2, DRP1 and increased levels of cardioprotective SUR2A in hypoxia-reoxygenation, but did not have any effects
Like
Comment
Share
